Photocatalytic Removal of Pharmaceuticals from Greywater

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F60461373%3A22320%2F21%3A43922374" target="_blank" >RIV/60461373:22320/21:43922374 - isvavai.cz</a>
Alternative codes found
RIV/60461373:22330/21:43922374 RIV/60461373:22340/21:43922374 RIV/61388955:_____/21:00546303
Result on the web
<a href="https://www.mdpi.com/2073-4344/11/9/1125" target="_blank" >https://www.mdpi.com/2073-4344/11/9/1125</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.3390/catal11091125" target="_blank" >10.3390/catal11091125</a>

Result language
angličtina
Original language name
Photocatalytic Removal of Pharmaceuticals from Greywater
Original language description
High concentrations of pharmaceuticals have been detected in greywater effluents treated using up-to-date technologies. Finding a suitable additional treatment before this effluent is reused is urgently needed to ensure the reused water meets quality standards. This paper reports the use of heterogeneous photocatalysis on anatase and rutile nanopowders to remove naproxen, metformin and sulfamethoxazole, at practically relevant concentrations found in membrane bioreactor (MBR)-treated greywater. A low anatase concentration of 400 mg L−1 was sufficient to efficiently degrade the pharmaceuticals listed above, with complete degradation observed in 5 h. The effect of background species presented in greywater was, to some extent, comparable to that of the OH-radical scavenger. These results prove that photocatalysis using anatase TiO2 is a feasible additional treatment for greywater recycling
Czech name
—
Czech description
—

Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Publication year
2021
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)